Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lymphoseek vs Vital Blue Dye in Endometrial Cancer
NCT02589366Phase 1Terminated
- Sponsor
- University of California, San Diego
- Start
- Nov 2015
- Primary completion
- Apr 2018
- Modality
- Radiopharmaceutical, Biologic
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of technetium tc 99m tilmanocept in endometrial cancer (EC), sponsored by University of California, San Diego. Primary endpoint: Adverse Events. Started Nov 2015; status: terminated.
02
Drugs
technetium tc 99m tilmanocept
03
Conditions
endometrial cancer (EC)
Beyond the preview
Go deeper on NCT02589366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02589366.